E-mail

E-mail a Wiley Online Library Link

Hagop Youssoufian, Eric K. Rowinsky, James Tonra and Yiwen Li Targeting FMS-related tyrosine kinase receptor 3 with the human immunoglobulin G1 monoclonal antibody IMC-EB10 Cancer 116

Version of Record online: 2 FEB 2010 | DOI: 10.1002/cncr.24787

FMS-related tyrosine kinase receptor 3 (FLT3)-directed agents hold considerable promise in hematologic malignancies. IMC-EB10, a fully human monoclonal antibody targeting FLT3, was active in leukemia preclinical models and was the first antibody to enter clinical development in this setting.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH